Viewing Study NCT05090033


Ignite Creation Date: 2025-12-25 @ 2:42 AM
Ignite Modification Date: 2026-01-08 @ 11:59 AM
Study NCT ID: NCT05090033
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-14
First Post: 2021-09-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Characterizing the Use of Ofatumumab in a Real World Setting
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsing Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ofatumumab View
None NIS View
None RMS View